Nairobi, Kenya – On Tuesday, August 12, 2025, the Pharmacy and Poisons Board (PPB) convened a meeting with key stakeholders in the pharmaceutical sector to address critical issues affecting the industry.

Chaired by PPB Chief Executive Officer, Dr. F. M. Siyoi, the meeting focused on stakeholders’ concerns, particularly regarding the Market Authorization of medical products in Kenya.

Dr. Siyoi emphasized the importance of stringent regulation to safeguard public health and called for strengthened collaboration to enhance public safety and regulatory oversight.

The meeting brought together representatives from the Kenya Association of Pharmaceutical Industry (KAPI), Kenya Pharmaceutical Distributors Association (KPDA), Medical Technology Industry Association of Kenya (MEDAK), Federation of Kenya Pharmaceutical Manufacturers (FKPM), and the Regulatory Affairs Professional Society of Kenya (RAPSK).